Evoke Wealth LLC Sells 1,934 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Evoke Wealth LLC reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 32.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,974 shares of the financial services provider’s stock after selling 1,934 shares during the quarter. Evoke Wealth LLC’s holdings in iShares Biotechnology ETF were worth $525,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of IBB. BNP Paribas Financial Markets raised its holdings in iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after purchasing an additional 538,899 shares during the period. Raymond James Financial Inc. bought a new position in iShares Biotechnology ETF in the 4th quarter worth $55,010,000. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after acquiring an additional 164,000 shares during the period. Aprio Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at about $18,476,000. Finally, Generali Investments CEE investicni spolecnost a.s. bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at about $11,370,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 1.5 %

NASDAQ:IBB opened at $134.09 on Wednesday. The business’s 50-day simple moving average is $136.26 and its two-hundred day simple moving average is $139.57. The stock has a market cap of $6.11 billion, a PE ratio of 27.83 and a beta of 0.77. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57.

iShares Biotechnology ETF Increases Dividend

The firm also recently declared a dividend, which will be paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th will be issued a dividend of $0.1212 per share. The ex-dividend date is Tuesday, March 18th. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.